MediPharm Labs Launches LABS CANNABIS, A New and Innovative Family of Health and Wellness Products - Seite 2

Further, in September 2020, Health Canada released its Summary Report: Consultation On Potential Market For Health Products Containing Cannabis That Would Not Require Practitioner Oversight² (findings were centred mainly on whether or not CBD should be allowed to be sold by retailers without strict regulations), revealing that nearly two-thirds of the 1,104 respondents polled are interested in buying "cannabis health products," with the majority of consumers interested in using the products to treat pain and inflammation such as joint or back pain, arthritis, migraines, or headaches. About 76% of consumers were aware of sub-populations who would be interested in CBD-dominant cannabis health products and felt anyone experiencing pain, trouble sleeping, or suffering from a chronic or mental health condition would benefit. Seniors, veterans, women experiencing menopause, pets or athletes were all groups of interest.

Visit the LABS Cannabis website to learn more at www.labscannabis.com
Follow LABS Cannabis on Instagram at https://www.instagram.com/labscannabis/
or Facebook at https://www.facebook.com/labsformulations

^{1)  EY Canada, 2019: Canadian cannabis consumer insights for legalization 2.0
2)  Health Canada, 2020: https://www.canada.ca/en/health-canada/services/publications/drugs-hea ...}

Corporate and Management Update

The Company announced the departure of Sybil Taylor, Chief Marketing Officer and, in addition, Chris Hobbs resigned from the Company’s Board of Directors effective October 19, 2020.

About MediPharm Labs

Founded in 2015, MediPharm Labs specializes in the production of purified, pharmaceutical quality cannabis oil and concentrates and advanced derivative products utilizing a Good Manufacturing Practices certified facility with ISO standard-built clean rooms. MediPharm Labs has invested in an expert, research driven team, state-of-the-art technology, downstream purification methodologies and purpose-built facilities with five primary extraction lines for delivery of pure, trusted and precision-dosed cannabis products for its customers. Through its wholesale and white label platforms, they formulate, consumer-test, process, package and distribute cannabis extracts and advanced cannabinoid-based products to domestic and international markets. As a global leader, MediPharm Labs has completed commercial exports to Australia and is nearing commercialization of its Australian Extraction facility. MediPharm Labs Australia was established in 2017.